Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Forslind

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Annals of the Rheumatic Diseases|April 28, 2016
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factorS Ajeganova, H W van Steenbergen, M K Verheul, et al.
Lancet (London, England)|August 12, 2009
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trialR F van Vollenhoven, S Ernestam, P Geborek, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohortsD P C de Rooy, J A B van Nies, M C Kapetanovic, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Annals of the Rheumatic Diseases|April 28, 2016
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factorS Ajeganova, H W van Steenbergen, M K Verheul, et al.
Lancet (London, England)|August 12, 2009
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trialR F van Vollenhoven, S Ernestam, P Geborek, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohortsD P C de Rooy, J A B van Nies, M C Kapetanovic, et al.
Pageof 4